
4D Molecular Therapeutics, Inc.
USD11.38
+0.28 (+2.57%)
CEO
David H. Kirn
IPO Date
2020-12-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.11
Prev. Close
$11.09
Day Low
$11.01
Day High
$11.96
52W Low
$4.21
52W High
$14.00
Market Cap
$0.59B
Volume
0.99M
| 19 Mar 2026 |
| Chardan Capital |
| Buy |
| Buy |
| maintain |
| 18 Dec 2025 | Chardan Capital | Buy | Buy | maintain |
| 11 Nov 2025 | Barclays | Overweight | Overweight | maintain |
| 11 Nov 2025 | Chardan Capital | Buy | Buy | maintain |
| 11 Nov 2025 | RBC Capital | Outperform | Outperform | maintain |
| 21 Oct 2025 | RBC Capital | Outperform | Outperform | maintain |
| 12 Aug 2025 | Chardan Capital | Buy | Buy | maintain |